June 30, 2026

The Delaware General Assembly's 2026 Legislative Session ran from January 13, 2026, to June 30, 2026.

The following major bills passed during the session.

  • Senate Bill 213 Compromise legislation to implement the Diamond State Hospital Cost Review Board, requiring unprecedented hospital financial transparency and accountability
  • SS 2 for Senate Bill 1Supports primary care while taking another meaningful step toward addressing healthcare affordability
  • HS 1 for House Bill 322 Seeks to protect healthcare workers, patients, and families from violence in hospital and healthcare settings
  • SS 1 for Senate Bill 13: Enhances access to hospital financial assistance programs
  • Senate Bill 313: Aims to prevent private equity from acquiring Delaware’s nonprofit acute care hospitals
  • House Bill 385Supports nurse preceptor programs to strengthen Delaware’s healthcare workforce

March 31, 2026

The 2026 Maryland General Assembly began on January 14, 2026, and will conclude on Monday, April 13, 2026. The MASHRM Legislative Committee has been closely monitoring bills including:

  • SB 269/HB 385- Evidence- Rebuttable Presumption of Medical Bills.  This bill would establish a rebuttable presumption in an action for personal injury or wrongful death that a medical bill from a health care provider is authentic, fair, and reasonable if the bill was properly provided in discovery.  Maryland Hospital Association has opposed this bill, noting that “Maryland already has one of the most challenging and unstable liability climates Sini the nation.  This bill would compound those challenges by shifting the burden of proving the veracity of medical bills onto defendants.  This structure is fundamentally unfair and encourages the submission of medical bills for health services that may not have been medically necessary.”  This bill is currently pending in the Senate Judicial Proceedings Committee. 

  • SB 871 - Civil Actions- Punitive Damages Awards - Surcharge.  This bill would provide that punitive damages may be awarded in a civil action only if the plaintiff proves by clear and convincing evidence that the defendant acted with gross negligence and would further require the State Court Administrator to assess a surcharge on a defendant against whom punitive damages are entered.  Maryland Hospital Association has opposed this bill noting that it would result in more frequent and substantially larger damage awards.  The bill is currently pending in the Senate Judicial Proceedings Committee. 

  • SB 792 - Hospitals - Immigration Enforcement Action.  This bill would require hospitals in MD to adopt a policy describing the protocol of the hospital when there is an immigration enforcement action at the hospital.  A third reading passed and the bill is currently pending in the House Health Committee.  
In the District of Columbia, the Committee on Health will hold a meeting to consider and vote on the “Prenatal and Postpartum Remote Patient Monitoring Clarification Amendment Act”  (B26-0356) on April 7, 2026.  As introduced, the bill would cover and reimburse remote patient monitoring of specific health care service and expenses for pregnant patients including monitoring of blood glucose levels. 
 
On the federal level, in March 2026 the “Federal Take Back Our Hospitals Act of 2026” was introduced, which aims to prohibit Medicare payments to hospitals and skilled nursing facilities that are owned or controlled by “covered firms” which would include private equity funds, REITs, etc.  The bill’s sponsors note that more than 400 hospitals and nursing homes nationwide are currently owned and operated by private equity firms.  The bill’s sponsors have also introduced legislation in March 2026 ("The Patient Safety and Whistleblower Protections Act") which aims to provide legal protection for health care whistleblowers who speak out regarding patient safety concerns.  

February 5, 2026

DC Council Advances Bill Maximizing Access to HIV / AIDS Prevention Care

The bill consists of three primary components. First, it prevents health insurers and benefit plans from using prescription information regarding HIV prevention treatment to set insurance rates or to determine insurance eligibility. Second, it prohibits insurers from restricting or delaying distribution of prescribed antiretroviral drugs intended to combat HIV and/or AIDS. And third, it would prevent insurers from imposing a deductible, co-pay, or other costs for any formulation of the newest class of anti-HIV and anti-AIDS drugs, known as pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP), meant to prevent HIV/AIDS infection in the first place.

Click here for more information.